Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Food Allergenic Extract [EPC]
Cnidium Monnieri Fruit is a botanical substance classified as a Non-Standardized Food and Plant Allergenic Extract [EPC], used in clinical immunology and traditional medicine for various inflammatory and dermatological conditions.
Name
Cnidium Monnieri Fruit
Raw Name
CNIDIUM MONNIERI FRUIT
Category
Non-Standardized Food Allergenic Extract [EPC]
Drug Count
5
Variant Count
5
Last Verified
February 17, 2026
About Cnidium Monnieri Fruit
Cnidium Monnieri Fruit is a botanical substance classified as a Non-Standardized Food and Plant Allergenic Extract [EPC], used in clinical immunology and traditional medicine for various inflammatory and dermatological conditions.
Detailed information about Cnidium Monnieri Fruit
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Cnidium Monnieri Fruit.
Cnidium Monnieri Fruit, derived from the plant Cnidium monnieri (L.) Cusson, is a botanical entity with a storied history in both traditional pharmacopeias and modern clinical immunology. In the contemporary regulatory landscape, it is formally classified as a Non-Standardized Food Allergenic Extract [EPC] and a Non-Standardized Plant Allergenic Extract [EPC]. This classification indicates its primary clinical utility in the Western medical context as a tool for the diagnosis and potentially the treatment of hypersensitivity reactions (allergies). However, its pharmacological profile extends far beyond simple allergenic testing, encompassing a wide array of bioactive compounds known as coumarins.
Cnidium Monnieri Fruit belongs to the Apiaceae family (the carrot or parsley family). In clinical practice, it is often referenced by its traditional Chinese medicine (TCM) name, She Chuang Zi. The fruit is harvested when ripe and typically processed through drying or extraction to isolate its active constituents. While not a 'drug' in the traditional synthetic sense, the FDA recognizes these extracts under the category of allergenic products, which are regulated to ensure they can effectively identify specific IgE-mediated sensitivities in patients.
Historically, Cnidium Monnieri has been used for centuries to treat skin conditions such as eczema (red, itchy skin), ringworm, and scabies. In modern pharmacological research, it is being scrutinized for its potential roles in bone health, male fertility, and neuroprotection. Despite its long history, patients must understand that 'non-standardized' means the potency of the extract can vary between manufacturers, making professional medical supervision essential.
The mechanism of action for Cnidium Monnieri Fruit is multifaceted, depending on whether it is being used as a diagnostic allergen or a therapeutic agent.
When used as a diagnostic extract, Cnidium Monnieri Fruit works by eliciting a localized Type I hypersensitivity reaction. When a small amount of the extract is introduced to the skin (via prick or intradermal testing), it interacts with specific Immunoglobulin E (IgE) antibodies bound to the surface of mast cells. If the patient is sensitized to Cnidium Monnieri proteins, this interaction triggers degranulation, releasing histamine and other inflammatory mediators. This results in a 'wheal and flare' reaction, allowing clinicians to confirm an allergy.
The primary bioactive constituent of Cnidium Monnieri is Osthole, a natural coumarin derivative. Osthole exhibits several complex molecular mechanisms:
The pharmacokinetics of Cnidium Monnieri Fruit are largely studied through its marker compound, Osthole.
Cnidium Monnieri Fruit is available in several preparations, though availability varies by clinical setting:
> Important: Only your healthcare provider can determine if Cnidium Monnieri Fruit is right for your specific condition. The use of non-standardized extracts carries risks of variable potency and purity.
Dosage for Cnidium Monnieri Fruit varies significantly based on the intended use and the concentration of the extract.
Cnidium Monnieri Fruit is not recommended for use in children under the age of 18. There is a profound lack of safety data regarding its effects on developing endocrine systems and its potential for causing severe allergic reactions in pediatric populations. If an allergist deems testing necessary, it must be performed in a controlled clinical environment with emergency resuscitation equipment available.
Specific dosing adjustments for patients with kidney disease have not been established. However, since metabolites are excreted renally, patients with a GFR (Glomerular Filtration Rate) below 30 mL/min should use this substance with extreme caution, as accumulation may occur.
Because Cnidium Monnieri is extensively metabolized by the liver, it is contraindicated in patients with significant hepatic impairment or active liver disease. Coumarins can place additional metabolic stress on hepatocytes (liver cells).
Older adults should start at the lowest possible dose. The risk of photosensitivity (increased sensitivity to sunlight) and potential interactions with cardiovascular medications is higher in this population.
If you miss a dose of an oral Cnidium Monnieri supplement, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up, as this increases the risk of side effects like nausea or photosensitivity.
Signs of an overdose of Cnidium Monnieri Fruit may include:
In the event of a suspected overdose, contact your local poison control center or seek emergency medical attention immediately. Treatment is primarily supportive, focusing on airway management and fluid resuscitation.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. Non-standardized products can vary in strength, making self-dosing dangerous.
> Warning: Stop taking Cnidium Monnieri Fruit and call your doctor immediately if you experience any of these.
Chronic use of Cnidium Monnieri Fruit has not been extensively studied in high-quality human trials. However, based on its chemical profile, long-term concerns include:
No FDA black box warnings currently exist for Cnidium Monnieri Fruit. However, as a non-standardized allergenic extract, it carries a general warning regarding the risk of systemic allergic reactions including anaphylaxis during diagnostic procedures. Clinicians are advised to have epinephrine (1:1000) readily available during administration.
Report any unusual symptoms to your healthcare provider. Your feedback helps in monitoring the safety of non-standardized botanical products.
Cnidium Monnieri Fruit is a potent botanical extract that must be handled with care. Because it is a non-standardized product, the concentration of active coumarins can vary significantly between batches. Patients should never substitute one brand for another without consulting a pharmacist or physician.
No FDA black box warnings for Cnidium Monnieri Fruit. However, the FDA requires all allergenic extracts to carry warnings regarding the potential for severe systemic reactions.
If you are using Cnidium Monnieri Fruit for an extended period (more than 4 weeks), your healthcare provider may require the following tests:
Cnidium Monnieri Fruit may cause dizziness or lightheadedness in some patients. Do not drive or operate heavy machinery until you know how this substance affects you. If you experience vertigo or blurred vision, cease these activities immediately.
Alcohol should be avoided or strictly limited while taking Cnidium Monnieri Fruit. Alcohol can increase the risk of dizziness and may exacerbate the potential for liver toxicity when combined with coumarin-containing extracts.
There is no known withdrawal syndrome associated with the sudden discontinuation of Cnidium Monnieri Fruit. However, if you are using it for a chronic condition like eczema, symptoms may return upon stopping. It is always best to taper off any supplement under medical supervision to monitor for the return of symptoms.
> Important: Discuss all your medical conditions with your healthcare provider before starting Cnidium Monnieri Fruit. Provide a full list of all other medications to prevent dangerous interactions.
For each major interaction, the mechanism usually involves the Cytochrome P450 3A4 enzyme system. Osthole is both a substrate and a potential modulator of this system. The clinical consequence is typically an alteration in the drug's plasma concentration, leading to either toxicity or therapeutic failure.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A comprehensive review is the only way to ensure your safety.
Cnidium Monnieri Fruit must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis by a physician:
Patients should be aware of cross-sensitivity. If you are allergic to celery, cumin, coriander, or fennel, you have a high probability of reacting to Cnidium Monnieri Fruit. Always inform your allergist of these food allergies before undergoing testing.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing or recommending Cnidium Monnieri Fruit. Do not self-initiate therapy if you have any of the conditions listed above.
Cnidium Monnieri Fruit is considered unsafe during pregnancy. Traditional use and animal data suggest it acts as an emmenagogue (stimulates blood flow in the pelvic area) and may have abortifacient properties (induces abortion). Furthermore, the coumarin constituents can cross the placental barrier, potentially affecting fetal development. There are no controlled data in human pregnancy; therefore, the risk significantly outweighs any perceived benefit.
It is not known if the active constituents of Cnidium Monnieri Fruit, such as osthole, are excreted in human milk. Due to the potential for hormonal modulation and the lack of safety data in infants, breastfeeding women should avoid using this supplement. Infants have immature hepatic metabolic pathways and may be unable to clear coumarin derivatives, leading to potential toxicity.
Safety and effectiveness in pediatric patients (under 18 years of age) have not been established. Use in children is generally discouraged except for diagnostic allergy testing performed by a specialist. There is particular concern regarding the impact of phytoestrogens on prepubertal growth and hormonal development.
Clinical studies have not included sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. However, geriatric patients often have reduced renal and hepatic clearance. There is also an increased risk of falls if the drug causes dizziness or orthostatic hypotension. Polypharmacy (taking multiple medications) in the elderly significantly increases the risk of drug-drug interactions with Cnidium Monnieri.
No specific guidelines exist for GFR-based adjustments. However, cautious use is advised in patients with Stage 4 or 5 chronic kidney disease. Monitoring of fluid status and electrolyte balance is recommended if high doses are used.
Cnidium Monnieri Fruit is contraindicated in patients with moderate to severe hepatic impairment (Child-Pugh Class B or C). In mild impairment, if use is deemed absolutely necessary, frequent monitoring of liver enzymes is mandatory.
> Important: Special populations require individualized medical assessment. Never administer this substance to a child or a pregnant woman without direct obstetric or pediatric specialist approval.
Cnidium Monnieri Fruit exerts its effects through a complex interplay of coumarin derivatives. The primary compound, Osthole, works by:
| Parameter | Value |
|---|---|
| Bioavailability | 10% - 15% (Oral) |
| Protein Binding | >90% (Primarily Albumin) |
| Half-life | 2 - 4 hours |
| Tmax | 1 - 2 hours |
| Metabolism | Hepatic (CYP3A4, CYP2D6) |
| Excretion | Renal (70%), Fecal (25%) |
Cnidium Monnieri Fruit is classified as a Non-Standardized Plant Allergenic Extract. It belongs to the therapeutic class of Immunological Desensitizing Agents when used in allergy, and Botanical Coumarins when used as a dietary supplement.
Medications containing this ingredient
Common questions about Cnidium Monnieri Fruit
Cnidium Monnieri Fruit is primarily used in clinical settings as an allergenic extract to diagnose specific plant allergies through skin testing. In traditional medicine and as a supplement, it is often used to treat skin conditions like eczema, improve sexual health, and support bone density. Some research suggests it may have anti-inflammatory and anti-allergic properties by inhibiting histamine release. However, many of these uses are based on traditional practice rather than large-scale FDA clinical trials. Always consult a healthcare provider before using it for any therapeutic purpose.
The most common side effect is increased photosensitivity, which makes your skin much more susceptible to sunburn and UV damage. Many users also report mild gastrointestinal issues such as nausea, bloating, or stomach upset when taking the fruit orally. Dizziness and headaches are also frequently noted, likely due to the extract's effect on blood vessel dilation. In rare cases, it can cause allergic skin reactions or elevated liver enzymes. It is vital to monitor your body's response and report any persistent symptoms to a doctor.
It is generally advised to avoid alcohol while taking Cnidium Monnieri Fruit. Both alcohol and the active compounds in the fruit are processed by the liver, and combining them may increase the risk of hepatic strain or toxicity. Additionally, alcohol can worsen the dizziness and lightheadedness that some people experience while using this supplement. Alcohol may also interfere with the management of skin conditions for which Cnidium is often used. To ensure safety and efficacy, discuss your alcohol consumption with your healthcare provider.
No, Cnidium Monnieri Fruit is considered unsafe for use during pregnancy. It contains compounds that may stimulate uterine contractions, which could potentially lead to a miscarriage or premature labor. Animal studies have also raised concerns about its potential to cause developmental issues in the fetus. Because there is no established safe dose for pregnant women, it should be strictly avoided. If you discover you are pregnant while taking this supplement, stop use immediately and contact your obstetrician.
The time it takes to see results depends on the reason for use. For allergy diagnostic testing, the reaction occurs almost immediately, typically within 15 to 20 minutes of skin contact. For chronic conditions like eczema or for supporting bone health, it may take several weeks of consistent use before any noticeable benefits occur. Most clinical studies on its active component, osthole, observe changes over a period of 4 to 12 weeks. Do not expect immediate results for long-term health goals.
Yes, you can generally stop taking Cnidium Monnieri Fruit suddenly without experiencing physical withdrawal symptoms. Unlike some prescription medications, it does not cause chemical dependency. However, if you were using it to manage a specific condition like itchy skin or inflammation, your symptoms may return shortly after you stop. It is always recommended to discuss your plan to discontinue any supplement with your doctor. They can help you determine if an alternative treatment is necessary.
If you miss a dose, take it as soon as you remember, unless it is nearly time for your next scheduled dose. In that case, skip the missed dose and continue with your regular routine. Never take two doses at once to make up for a missed one, as this increases the risk of side effects like nausea or dizziness. Consistency is important for botanical supplements, so try to take it at the same time each day. Setting a reminder on your phone can help you stay on track with your regimen.
There is currently no clinical evidence to suggest that Cnidium Monnieri Fruit causes weight gain. In fact, some preliminary animal research has investigated its active component, osthole, for its potential to improve lipid metabolism and reduce fat accumulation. However, these effects have not been proven in humans. If you experience rapid or unexplained weight gain while taking this supplement, it is likely due to another underlying cause. You should consult your healthcare provider to investigate any significant changes in body weight.
Cnidium Monnieri Fruit has several significant drug interactions and should be used cautiously with other medications. It can interact with blood thinners like warfarin, potentially increasing the risk of bleeding. It may also interact with medications processed by the liver's CYP3A4 enzyme, such as certain heart medications or sedatives. Combining it with other photosensitizing drugs or PDE-5 inhibitors (like Viagra) can also be dangerous. Always provide your doctor or pharmacist with a complete list of your current medications before starting this supplement.
Cnidium Monnieri Fruit is a natural botanical product and is not 'generic' in the way synthetic prescription drugs are. It is sold by various manufacturers as a dietary supplement or as a non-standardized allergenic extract. Because these products are not standardized by a single regulatory body, the quality and concentration of active ingredients can vary widely between brands. You should look for products that have been third-party tested for purity and potency. Always purchase from reputable sources to ensure you are getting a high-quality extract.